These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38706215)
1. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1. Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215 [No Abstract] [Full Text] [Related]
2. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma. Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179 [TBL] [Abstract][Full Text] [Related]
3. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma. Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435 [TBL] [Abstract][Full Text] [Related]
4. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
6. ACSL4 upregulates IFI44 and IFI44L expression and promotes the proliferation and invasiveness of head and neck squamous cell carcinoma cells. Rupa D; Chuang HW; Hu CE; Su WM; Wu SR; Lee HS; Yuan TC Cancer Sci; 2024 Sep; 115(9):3026-3040. PubMed ID: 38989827 [TBL] [Abstract][Full Text] [Related]
7. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma. Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628 [TBL] [Abstract][Full Text] [Related]
8. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605 [TBL] [Abstract][Full Text] [Related]
10. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway. Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809 [TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related]
12. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway. Wang Q; Meng D; Shen S; Cao Y; Zhang P; Liu Y; Du L; Li H; Shao C; Dong Q Pathol Res Pract; 2024 Aug; 260():155481. PubMed ID: 39053135 [TBL] [Abstract][Full Text] [Related]
13. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073 [TBL] [Abstract][Full Text] [Related]
14. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226 [TBL] [Abstract][Full Text] [Related]
15. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623 [TBL] [Abstract][Full Text] [Related]
16. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma. Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709 [TBL] [Abstract][Full Text] [Related]
18. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma. Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090 [TBL] [Abstract][Full Text] [Related]
19. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma. Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142 [No Abstract] [Full Text] [Related]
20. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis. Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]